Commitments and Contingencies - Additional Information (Detail) - USD ($)		3 Months Ended
	Jun. 15, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 16, 2021	Jul. 31, 2021
Commitments And Contingencies Disclosure [Line Items]
Percentage of common stock filed a lawsuit	5.00%
A G C Biologics Inc | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Remaining obligations		$ 0
A G C Biologics Inc | Marzeptacog Alfa Activated And Dalcinonacog Alfa | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Cost of Manufacturing Services			$ 700,000
Dalcinonacog Alfa | Service Agreements
Commitments And Contingencies Disclosure [Line Items]
Remaining obligations		0
Clinical trial services cost incurred on agreement termination		$ 800,000
Dalcinonacog Alfa | Service Agreements | Maximum
Commitments And Contingencies Disclosure [Line Items]
Cost of services as per agreement					$ 6,500,000
Catalent Indiana, LLC. | Dalcinonacog alfa.
Commitments And Contingencies Disclosure [Line Items]
Firm work order supporting clinical trials				$ 300,000